Demyelination after anti-TNF therapy: Who is at risk?

Míreanna comhchosúla

• Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series
  de réir: Abel Hamdan, et al.
  Foilsithe / Cruthaithe: (2024-07-01)
• Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C
  de réir: Williams, I, et al.
  Foilsithe / Cruthaithe: (2022)
• PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders
  de réir: Sinah Engel, et al.
  Foilsithe / Cruthaithe: (2020-01-01)
• Anti-TNF therapy
  de réir: Udalova, I, et al.
  Foilsithe / Cruthaithe: (2016)
• The Role of Non-Selective TNF Inhibitors in Demyelinating Events
  de réir: Line Buch Kristensen, et al.
  Foilsithe / Cruthaithe: (2021-01-01)